What is the Y-tunnus number of Medicator Oy?

Medicator Oy is registered with PRH / YTJ under Y-tunnus 1013304-2.

What is the revenue of Medicator Oy?

Medicator Oy reported revenue of EUR 32K in 2025.

Who is the CEO of Medicator Oy?

Joel Johannes Hukki is Deputy Member of Medicator Oy, in role since 2016.

Who is the chairman of Medicator Oy?

Ada Laura Emilia Hukki-Aitala chairs the board of Medicator Oy, in role since 2016.

Where is Medicator Oy headquartered?

Medicator Oy's registered address is Kruunuvuorenkatu 2-B52.

Riskpilot← Back to search

Sign inGet full access

Medicator Oy

OYActive

Y-tunnus 1013304-2Kruunuvuorenkatu 2B-252, 00160 HelsinkiMedical specialists activities · NACE 8622Est. 1995— employees

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2021	2022	2023	2024	2025
Revenue	63	55	45	33	32
Staff expenses	—	—	—	—	—
EBITDA	47	23	122	134	105
Depreciation & amort.	−4	−4	19	18	14
EBIT	42	20	−51	−86	−56
Net financials	−18	−15	215	—	—
Profit before tax	25	5	165	−165	−81
Tax	−1	0	33	−0	—
Net profit	26	5	132	−165	−81

Balance sheet

EUR thousands

Item	2021	2022	2023	2024	2025
Total assets	1 876	1 844	1 689	1 345	1 157
Equity	923	849	908	675	521
Long-term debt	783	694	457	408	173
Short-term debt	169	301	324	263	463
Total debt	953	995	781	671	636

Financial ratios

5-year trend

EBITDA margin

331.1%

This company

15.8%

Market median

+1996% vs market

20212025

Equity ratio

45.0%

This company

38.2%

Market median

+18% vs market

20212025

Return on equity

-15.5%

This company

18.4%

Market median

-184% vs market

20212025

Net profit margin

-253.0%

This company

8.1%

Market median

-3223% vs market

20212025

Asset turnover

0.03×

This company

1.12×

Market median

-97% vs market

20212025

Debt / equity

1.22×

This company

0.62×

Market median

-97% vs market

20212025

Annual reports & filings

Annual report 2025
Filed via PRH / YTJ · Period 2024-02-01 – 2025-01-31
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-02-01 – 2024-01-31
View PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-02-01 – 2023-01-31
View PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-02-01 – 2022-01-31
View PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-02-01 – 2021-01-31
View PDF

Medicator Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Medicator Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Medicator Oy